Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

567 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Soluble Urokinase Receptor and Acute Kidney Injury.
Hayek SS, Leaf DE, Samman Tahhan A, Raad M, Sharma S, Waikar SS, Sever S, Camacho A, Wang X, Dande RR, Ibrahim NE, Baron RM, Altintas MM, Wei C, Sheikh-Hamad D, Pan JS, Holliday MW Jr, Januzzi JL, Weisbord SD, Quyyumi AA, Reiser J. Hayek SS, et al. Among authors: quyyumi aa. N Engl J Med. 2020 Jan 30;382(5):416-426. doi: 10.1056/NEJMoa1911481. N Engl J Med. 2020. PMID: 31995687 Free PMC article.
Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse events.
Eapen DJ, Manocha P, Ghasemzadeh N, Patel RS, Al Kassem H, Hammadah M, Veledar E, Le NA, Pielak T, Thorball CW, Velegraki A, Kremastinos DT, Lerakis S, Sperling L, Quyyumi AA. Eapen DJ, et al. Among authors: quyyumi aa. J Am Heart Assoc. 2014 Oct 23;3(5):e001118. doi: 10.1161/JAHA.114.001118. J Am Heart Assoc. 2014. PMID: 25341887 Free PMC article.
Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease.
Mekonnen G, Corban MT, Hung OY, Eshtehardi P, Eapen DJ, Al-Kassem H, Rasoul-Arzrumly E, Gogas BD, McDaniel MC, Pielak T, Thorball CW, Sperling L, Quyyumi AA, Samady H. Mekonnen G, et al. Among authors: quyyumi aa. Atherosclerosis. 2015 Mar;239(1):55-60. doi: 10.1016/j.atherosclerosis.2014.12.025. Epub 2014 Dec 20. Atherosclerosis. 2015. PMID: 25574858
Tumor necrosis factor-alpha antagonism with etanercept improves endothelial progenitor cell counts in patients with psoriasis: etanercept, vascular function and endothelial progenitor cells in psoriasis.
Hayek SS, Neuman R, Kavtaradze N, Sher S, Jones D, Li Q, Zhao L, Chen SC, Waller E, Quyyumi A. Hayek SS, et al. Int J Cardiol. 2015 Mar 1;182:387-9. doi: 10.1016/j.ijcard.2014.12.093. Epub 2014 Dec 27. Int J Cardiol. 2015. PMID: 25617605 Free PMC article. No abstract available.
567 results